CA2798571A1 - Stem cell bank for personalized medicine - Google Patents

Stem cell bank for personalized medicine Download PDF

Info

Publication number
CA2798571A1
CA2798571A1 CA2798571A CA2798571A CA2798571A1 CA 2798571 A1 CA2798571 A1 CA 2798571A1 CA 2798571 A CA2798571 A CA 2798571A CA 2798571 A CA2798571 A CA 2798571A CA 2798571 A1 CA2798571 A1 CA 2798571A1
Authority
CA
Canada
Prior art keywords
stem cells
cells
stem
stem cell
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2798571A
Other languages
English (en)
French (fr)
Inventor
Ehud Marom
Original Assignee
Stem Cell Medicine Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stem Cell Medicine Ltd filed Critical Stem Cell Medicine Ltd
Publication of CA2798571A1 publication Critical patent/CA2798571A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60—In silico combinatorial chemistry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioethics (AREA)
  • Reproductive Health (AREA)
  • Databases & Information Systems (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Library & Information Science (AREA)
  • Computing Systems (AREA)
  • Crystallography & Structural Chemistry (AREA)
CA2798571A 2010-05-06 2011-05-05 Stem cell bank for personalized medicine Abandoned CA2798571A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33184210P 2010-05-06 2010-05-06
US61/331,842 2010-05-06
US201161429773P 2011-01-05 2011-01-05
US61/429,773 2011-01-05
PCT/IL2011/000362 WO2011138786A2 (en) 2010-05-06 2011-05-05 Stem cell bank for personalized medicine

Publications (1)

Publication Number Publication Date
CA2798571A1 true CA2798571A1 (en) 2011-11-10

Family

ID=44904175

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2798571A Abandoned CA2798571A1 (en) 2010-05-06 2011-05-05 Stem cell bank for personalized medicine

Country Status (7)

Country Link
US (2) US20130052169A1 (enExample)
EP (1) EP2566955A4 (enExample)
JP (3) JP2013528368A (enExample)
CN (1) CN103025865A (enExample)
AU (1) AU2011249406B2 (enExample)
CA (1) CA2798571A1 (enExample)
WO (1) WO2011138786A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
US9358320B2 (en) 2008-04-25 2016-06-07 Allosource Multi-layer tissue patches
US9162011B2 (en) 2011-12-19 2015-10-20 Allosource Flowable matrix compositions and methods
JP2015521630A (ja) * 2012-06-26 2015-07-30 ラスティー プロパティー ホールディングス プロプライエタリー リミテッド 頭痛の頻度および／または重症度を下げるための組成物および方法
EP2968646B1 (en) 2013-03-13 2019-05-29 AlloSource Fascia fibrous compositions and methods for their use and manufacture
WO2014150784A1 (en) 2013-03-15 2014-09-25 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
US10738323B2 (en) 2013-07-12 2020-08-11 Cedars-Sinai Medical Center Generation of induced pluripotent stem cells from normal human mammary epithelial cells
US10265347B2 (en) 2013-08-29 2019-04-23 Norimasa Miura Biomolecular group related to cell anti-aging
US9795707B2 (en) 2013-12-06 2017-10-24 Allosource Methods of drying sheets of donor-provided human birth tissue
EP3102124A1 (en) * 2014-02-06 2016-12-14 Stryker European Holdings I, LLC Bone marrow harvesting and storage
US9867853B2 (en) 2014-05-30 2018-01-16 International Cell Technologies Inc. Method of providing cellular based immune enhancement for restoring immunity and preventing age related diseases
US10264976B2 (en) 2014-12-26 2019-04-23 The University Of Akron Biocompatible flavonoid compounds for organelle and cell imaging
EP3273881B1 (en) 2015-03-24 2019-10-09 Stryker European Holdings I, LLC Bone marrow harvesting device
CN108289915A (zh) * 2015-11-24 2018-07-17 日本乐敦制药株式会社 包含脂肪组织来源基质细胞的肝病治疗剂及其制造方法
GB201600597D0 (en) * 2016-01-12 2016-02-24 Occhipinti Luigi G And Pluchino Stefano And Cambridge Innovation Technologies Consulting Ltd Banking of stem cells and business methods related to the same
US11572545B2 (en) 2016-06-16 2023-02-07 Cedars-Sinai Medical Center Efficient method for reprogramming blood to induced pluripotent stem cells
US10221395B2 (en) 2016-06-16 2019-03-05 Cedars-Sinai Medical Center Efficient method for reprogramming blood to induced pluripotent stem cells
US10354218B2 (en) 2016-08-04 2019-07-16 Fanuc Corporation System and method for iPS cell bank using internet technology
WO2018026576A1 (en) * 2016-08-04 2018-02-08 Good Start Genetics, Inc. Genomic analysis of cord blood
WO2018027116A1 (en) * 2016-08-05 2018-02-08 Jay Yadav Plasma banking to mitigate aging
US10772986B2 (en) 2017-01-26 2020-09-15 Allosource Fascia fibrous compositions and methods for their use and manufacture
WO2018170046A1 (en) * 2017-03-14 2018-09-20 Orig3N, Inc. Hla-indexed repository of ipscs and ipsc-derived stem cells, and related systems and methods
CA3090592A1 (en) * 2017-09-01 2019-03-07 Orig3N, Inc. Allogeneic car-t platform using hla-matched bank of ipscs, and related compositions, systems, and methods
US20210187040A1 (en) * 2017-09-01 2021-06-24 Orig3N, Inc. Ipsc-derived secretome compositions, and related systems and methods
CA3074734A1 (en) 2017-09-06 2019-03-14 Nant Holdings Ip, Llc Hla tissue matching and methods therefor
US20190338244A1 (en) * 2017-11-30 2019-11-07 New York Medical College Multipotent adult stem cells: characterization and use
WO2020129366A1 (ja) * 2018-12-21 2020-06-25 アイ ピース， インコーポレイテッド 健康リスク情報管理装置、健康リスク情報管理方法、およびプログラム
CN114242191A (zh) * 2021-10-29 2022-03-25 南京国青血液净化科技有限公司 干细胞自助配型方法及配型装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040091936A1 (en) * 2002-05-24 2004-05-13 Michael West Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
CA2548580A1 (en) * 2003-04-03 2004-10-21 Neostem, Inc. Elective collection and banking of autologous peripheral blood stem cells
JP2007531116A (ja) * 2004-03-26 2007-11-01 セルジーン・コーポレーション 幹細胞バンクを提供するためのシステム及び方法
US8883507B2 (en) * 2005-10-18 2014-11-11 The Regents Of The University Of Colorado Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells
WO2007059084A2 (en) * 2005-11-14 2007-05-24 The New England Medical Center Hospitals, Inc. Methods for preparing cord matrix stem cells (cmsc) for long term storage and for preparing a segment of umbilical cord for cryopreservation
US20090227032A1 (en) * 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
AU2006332679A1 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Co-culture of placental stem cells and stem cells from a second source
EP2489728A1 (en) * 2006-06-15 2012-08-22 Neostem, Inc Processing procedure for peripheral blood stem cells
WO2008127670A1 (en) * 2007-04-11 2008-10-23 Alecia Hathaway Autologous/allogeneic human dna grafting, anti-and reserve aging stem cell, and bone marrow compositions/methods

Also Published As

Publication number Publication date
AU2011249406B2 (en) 2015-05-14
EP2566955A4 (en) 2014-10-29
US20130052169A1 (en) 2013-02-28
EP2566955A2 (en) 2013-03-13
US20160122709A1 (en) 2016-05-05
AU2011249406A1 (en) 2012-11-29
CN103025865A (zh) 2013-04-03
JP2018121650A (ja) 2018-08-09
WO2011138786A3 (en) 2012-04-12
JP2013528368A (ja) 2013-07-11
WO2011138786A2 (en) 2011-11-10
JP2016189783A (ja) 2016-11-10

Similar Documents

Publication Publication Date Title
AU2011249406B2 (en) Stem cell bank for personalized medicine
KR100871984B1 (ko) 태반 조직 유래 다능성 줄기세포 및 이를 함유하는세포치료제
TWI686202B (zh) 體幹細胞
Mauro et al. Isolation, characterization, and in vitro differentiation of ovine amniotic stem cells
US20090280093A1 (en) Compositions and populations of cells obtained from the umbilical cord and methods of producing the same
US20080226612A1 (en) Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof
Matsuda et al. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development
KR20200012991A (ko) 개과동물 양막-유래 다분화능 줄기세포
WO2003080822A1 (en) Placenta-origin mesenchymal cells and medicinal use thereof
US20060030039A1 (en) Placental stem cell and methods thereof
Fink et al. Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum
Stanworth et al. Stem cells: progress in research and edging towards the clinical setting
US20090016997A1 (en) Autologous/allogeneic human DNA grafting, anti-and reverse aging stem cell, and bone marrow compositions/methods
US20160158292A1 (en) Method and apparatus for recovery of umbilical cord tissue derived regenerative cells and uses thereof
Jain et al. Stem cells research prospects towards precision medicine.
Azeem et al. Umbilical cord stem cells: A review
Shroff 660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy
Law et al. Scientific Basis for Stem Cell Therapy
Siddiqui et al. Stem Cells
Srinivas et al. AN ESSENTIAL PARAMETERS OF IMPORTANCE OF STEM CELLS IN MODERN MEDICINE INCLUDE EXAMPLES OF STEM CELLS THERAPIES IN MEDICINE, NEURO DEGENERATIVE DISEASES AND PHARMACOLOGICAL TESTING
Fergany Faculty of Biotechnology Research Project RS400 (Pre-Cryopreservation Umbilical Cord Blood quality: The significance of Gestational age and
CN113521107A (zh) 用于治疗骨骼缺损的体干细胞
Anderson et al. Keynote Lectures
KR20210046196A (ko) 말과동물 양막-유래 중간엽 줄기세포 및 이의 용도
Akbari et al. The study of used of adult stem cells differentiated into the hematopoietic cells for use in the therapy of marrow ablated horse

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160420

FZDE Discontinued

Effective date: 20200831